US2006008537A1PendingUtilityA1
Method of treating acne
Individually held — no corporate assignee on recordPriority: Jul 7, 2004Filed: Jul 7, 2004Published: Jan 12, 2006
Est. expiryJul 7, 2024(expired)· nominal 20-yr term from priority
A61K 45/06A61K 33/04
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention features a composition including an anti-acne agent, an antimicrobial agent, and a lactate, and the use thereof in the treatment of acne.
Claims
exact text as granted — not AI-modified1 . A method of treating acne comprising applying to an area of skin in need of such treatment a composition comprising an anti-acne agent, an antimicrobial agent, and a lactate.
2 . A method of claim 1 , wherein said method of treating acne comprises treating pre-emergent pimples.
3 . A method of claim 1 , wherein said method of treating acne comprises treating blackheads.
4 . A method of claim 1 , wherein the appearance of said acne is reduced within about eight hours.
5 . The method according to claim 1 wherein the anti-acne agent is selected from the group consisting of salicylic acid, benzoyl peroxide, sulphur, retinoic acid, azaleic acid, clindamycin, adapalene, erythromycin, sodium sulfacetamide, and combinations thereof.
6 . The method according to claim 1 wherein the antimicrobial agent is selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, 3-iodo-2-propynyl-N-butylcarbamate, hexetidine (5-amino-1,3-bis-(2-ethylhexyl)-5-methyl-hexahydropyrimidine), Quaternium 15, triclosan, chlorhexidine digluconate, and combinations thereof.
7 . The method according to claim 5 wherein the antimicrobial agent is selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, 3-iodo-2-propynyl-N-butylcarbamate, hexetidine (5-amino-1,3-bis-(2-ethylhexyl)-5-methyl-hexahydropyrimidine), Quaternium 15, triclosan, chlorhexidine digluconate, and combinations thereof.
8 . The method according to claim 1 wherein said lactate is selected from the group consisting of C 12 -C 16 alkyl lactates and combinations thereof.
9 . The method according to claim 5 wherein said lactate is selected from the group consisting of C 12 -C 16 alkyl lactates and combinations thereof.
10 . The method according to claim 7 wherein said lactate is selected from the group consisting of C 12 -C 16 alkyl lactates and combinations thereof.
11 . The method according to claim 1 wherein said anti-acne agent is salicylic acid, said antimicrobial agent is benzalkonium chloride, and said lactate is is selected from the group consisting of C 12 -C 16 alkyl lactates and combinations thereof.
12 . The method according to claim 1 wherein said composition further comprises a phospolipid.
13 . The method according to claim 11 wherein said composition further comprises a phospolipid.
14 . The method according to claim 1 wherein said composition further comprises a phospolipid.
15 . The method according to claim 11 wherein said composition further comprises a phospolipid.
16 . The method according to claim 15 wherein said phospolipid is sodium coco PG-Dimonium Chloride phosphate.
17 . A method of promoting a composition comprising an anti-acne agent, an antimicrobial agent, and a lactate, said method comprising promoting said composition for the treatment of acne.
18 . A method of claim 17 , wherein said method comprises promoting said composition for the treatment of pre-emergent pimples.
19 . A method of claim 17 , wherein said method comprises promoting said composition for the treatment of blackheads.
20 . A method of claim 17 , wherein said method comprises promoting the composition for reducing the appearance of said acne within about eight hours.
21 . The method of claim 17 wherein said anti-acne agent is salicylic acid, said antimicrobial agent is benzalkonium chloride, and said lactate is C 12 -C 15 alkyl lactate.
22 . The method of claim 17 wherein said composition further comprises a phospolipid.Join the waitlist — get patent alerts
Track US2006008537A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.